Novartis Investigative Site

Rennes, Ille Et Vilaine 35062

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Hepatocellular Carcinoma (HCC), Solid Malignancies

Studies at this site

• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression — Completed